KLRK1 and neoplasm: Ligands for the natural killer group 2 member D (NKG2D), an NK-cell activating receptor [8], are primarily expressed on most types of tumor cells, including hematological and solid tumors, but are normally absent or expressed in low levels on healthy tissues [9,10].